Non c carenza di tutti i dosaggi del farmaco, ma di un dosaggio maggiore
A 2024 Swedish study followed 3,249 MS patients for an average of 10.6 years and found that obesity was associated with: 4 43% higher risk of reaching EDSS 3 (moderate disability) 40% higher risk of reaching EDSS 4 (significant walking impairment) More rapid cognitive decline Higher MRI activity showing new brain lesions A German study of 1,066 MS patients found that obese patients reached disability milestones more quickly than those with normal weight
Lemme GLP-1 Daily is made from a blend of saffron extract, lemon fruit extract, and red orange fruit extract
Bariatric surgery, on the other hand, offers a straightforward solution by directly addressing the root causes of obesity
However, effectiveness depends on dosage, formulation, and individual response